Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can computer therapy and peer coaching help people on opioid treatment stay Drug-Free?

NCT ID NCT06102200

Disease control Sponsor: Prisma Health-Upstate Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding computer-based cognitive behavioral therapy (CBT4CBT) and peer recovery coaching to standard buprenorphine treatment helps reduce illicit drug use. 92 adults with opioid use disorder were randomly assigned to receive buprenorphine alone, buprenorphine plus CBT4CBT, or buprenorphine plus both CBT4CBT and coaching. The main goal was to see if the extra support lowered the number of positive saliva drug tests during the 8-week treatment period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

92 people

The number who actually took part.

Started

Oct 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults (≥18 years of age); 2. DSM-V diagnosis of OUD, confirmed via electronic medical record review; 3. Currently receiving SL buprenorphine/ naloxone and/or buprenorphine HCL; 4. Initiated SL buprenorphine within the last 30 days; 5. Willing to accept a random assignment to either treatment arm: 6. Adequate computer skills Exclusion Criteria: 1. Severe medical or psychiatric disability that could impair the ability to perform study related activities (determined by the clinician); 2. Pregnancy, planning conception, or breast-feeding for female participants; 3. Inability to independently read and/or comprehend the consent form or other study materials; 4. Inability to read/speak English (inability to independently read and comprehend the consent form or other study materials); 5. Current suicidal ideation based on the Patient Health Questionnaire-9 6. Have taken or received any prescribed buprenorphine product within 30 days prior to the current treatment episode.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Standard of care Standard of care + CBT4CBT Standard of care + CBT4CBT + RC

Contacts and locations

Locations

  • Greenville Health System

    Greenville, South Carolina, 29605, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.